{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:59:57Z","timestamp":1770980397555,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.3816\/clm.2002.s.011","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T01:02:20Z","timestamp":1221181340000},"page":"S19-S25","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S1","title":["Challenges in the Management of Burkitt's Lymphoma"],"prefix":"10.3816","volume":"3","author":[{"given":"Alexandra M.","family":"Levine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2002.s.011_bib1","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1182\/blood.V97.12.3713","article-title":"The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features","volume":"97","author":"Braziel","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2002.s.011_bib2","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2002.s.011_bib3","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","article-title":"Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells","volume":"79","author":"Taub","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2002.s.011_bib4","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","article-title":"Molecular biology of Burkitt's lymphoma","volume":"18","author":"Hecht","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2002.s.011_bib6","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","article-title":"Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model","volume":"13","author":"Hollender","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib7","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1999.17.5.1558","article-title":"Small noncleaved, non-Burkitt's (Burkitt-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation","volume":"17","author":"Macpherson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood.V79.5.1282.1282","article-title":"Histogenetic correlations between subcategories of small noncleaved cell lymphomas","volume":"79","author":"Yano","year":"1992","journal-title":"Blood"},{"key":"10.3816\/CLM.2002.s.011_bib9","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","volume":"89","author":"The Non-Hodgkin's Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2002.s.011_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/1097-0142(19830915)52:6<1073::AID-CNCR2820520624>3.0.CO;2-F","article-title":"Small noncleaved follicular center cell (FCC) lymphoma: Burkitt and non-Burkitt variants in the United States. I. Clinical features","volume":"52","author":"Levine","year":"1983","journal-title":"Cancer"},{"key":"10.3816\/CLM.2002.s.011_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hon.660","article-title":"The new World Health Organization classification of lymphomas: the past, the present and the future","volume":"19","author":"Chan","year":"2001","journal-title":"Hematol Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.1991.9.6.941","article-title":"Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy","volume":"9","author":"McMaster","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib13","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.1994.12.10.2153","article-title":"Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to Pro-MACE-based combination chemotherapy","volume":"12","author":"Longo","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","article-title":"Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols","volume":"85","author":"Soussain","year":"1995","journal-title":"Blood"},{"key":"10.3816\/CLM.2002.s.011_bib15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small noncleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib16","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1200\/JCO.2001.19.20.4014","article-title":"Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251","volume":"19","author":"Lee","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib17","first-page":"2031","article-title":"Combined modality treatment of Burkitt's lymphoma","volume":"62","author":"Ziegler","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.3816\/CLM.2002.s.011_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1097-0142(19910715)68:2<233::AID-CNCR2820680203>3.0.CO;2-Q","article-title":"Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma","volume":"68","author":"McMaster","year":"1991","journal-title":"Cancer"},{"key":"10.3816\/CLM.2002.s.011_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1096-911X(200007)35:1<8::AID-MPO2>3.0.CO;2-P","article-title":"Improved outcome in childhood B-cell lymphoma with the intensified French LMB protocol","volume":"35","author":"Yaniv","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0037-1963(01)90040-X","article-title":"Treatment of high-grade lymphoid malignancies in adults","volume":"38","author":"Schiffer","year":"2001","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2002.s.011_bib22","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.leu.2400850","article-title":"Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies","volume":"11","author":"Pui","year":"1997","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2002.s.011_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","article-title":"Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma","volume":"19","author":"Pui","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib24","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2002.s.011_bib25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standarddose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2002.s.011_bib26","first-page":"26","article-title":"Dose-adjusted EPOCH chemotherapy (CT) with suspension of antiretroviral therapy (ART) for HIV-associated non-Hodgkin's lymphoma (HIV-NHL)","volume":"23","author":"Little","year":"2000","journal-title":"J AIDS"},{"key":"10.3816\/CLM.2002.s.011_bib27","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2002.s.011_bib28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.2001.02656.x","article-title":"Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone","volume":"112","author":"Navarro","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2002.s.011_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B","article-title":"Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma","volume":"91","author":"Vaccher","year":"2001","journal-title":"Cancer"},{"key":"10.3816\/CLM.2002.s.011_bib30","first-page":"30","article-title":"Infusional cyclophosphamide, doxorubicin, & etoposide in HIV-associated non-Hodgkin's lymphoma: a review of the Einstein, Aviano, and ECOG expreience in 182 patients","volume":"23","author":"Sparano","year":"2000","journal-title":"J AIDS"},{"key":"10.3816\/CLM.2002.s.011_bib31","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152696551170166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152696551170166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:42:06Z","timestamp":1588920126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152696551170166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":31,"alternative-id":["S152696551170166X"],"URL":"https:\/\/doi.org\/10.3816\/clm.2002.s.011","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}